Mexico Early Toxicity Testing Market Set to Reach USD 36.16 Million by 2030

According to Next Move Strategy Consulting, Mexico Early Toxicity Testing Market is predicted to reach USD 36.16 million with a CAGR of 16.07% till 2030.

The market is driven by rise in prevalence of chronic diseases such as cancer, diabetics, and strokes in the country, which propels the need for early toxicity testing to ensure safety of new drugs and treatments. Chronic diseases, with their enduring impact on public health and well-being, have emerged as formidable challenges across Mexico.

However, stringent regulations set by regulatory bodies such as the US FDA and the EMA require extensive and rigorous testing for drug development and safety, which can be time-consuming and expensive and restrain growth of the market. 

Request For FREE Sample: https://www.nextmsc.com/mexico-early-toxicity-testing-market/request-sample